Erythropoietin-producing cerebellar tumour
Copper deficiency anaemia
Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction
The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined?
The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia
Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma*
Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma
Early response to therapy and survival in multiple myeloma
A recombinant bispecific single-chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells
CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome
Prospective clinical evaluation of a LightCycler™-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias*
T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia
Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation
Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
No deterioration after 13 years in a stability study of a rabbit brain, plain, thromboplastin, RBT 1010, in rubber-stoppered ampoules
Diamond Blackfan anaemia in the UK
Ex vivo analysis of aberrant splicing induced by two donor site mutations in PKLR of a patient with severe pyruvate kinase deficiency